EVLVW — Evolv Technologies Holdings, Inc.

Summary of Evolv Technology Q3 2025 Earnings Call

1. Key Financial Results and Metrics

• Revenue: $42.9 million, a 57% increase year-over-year, driven by new customer acquisitions and expanded deployments.
• Annual Recurring Revenue (ARR): $117.2 million, reflecting a 25% year-over-year growth.
• Remaining Performance Obligation (RPO): Approximately $299 million, up from $275 million in Q2 2025.
• Adjusted EBITDA: Positive $5.1 million with an adjusted EBITDA margin of 12%.
• Gross Margin: 51%, down from 64% year-over-year, impacted by the transition from a distribution fulfillment model to direct purchase fulfillment.
• Cash Position: Increased to $56 million, up from $37 million at the end of Q2 2025.

2. Strategic Updates and Business Highlights

• Transitioned to a direct distribution model, allowing Evolv to capture 100% of the average revenue per unit (ARPU) and increasing recurring revenue over the subscription term.
• Welcomed over 60 new customers in Q3, with a focus on education, sports, and healthcare sectors.
• Launched new product versions, including Evolv Express 9.0 and eXpedite 1.2, enhancing user experience and operational efficiency.
• Established a strategic partnership with Plexus to expand production capacity and operational resiliency.
• Continued strong traction for the eXpedite bag screening solution, with 12 new customers added in Q3.

3. Forward Guidance and Outlook

• 2025 Revenue Guidance: Revised upward to $142 million - $145 million, reflecting a growth of 37% to 40%.
• 2026 Revenue Projection: Expected to be between $160 million - $165 million, with ARR growth anticipated to outpace total revenue growth, projected at least 20% year-over-year.
• Positive adjusted EBITDA expected for the full year 2025, with margins in the high single digits.

4. Challenges and Points of Concern

• The shift to direct fulfillment is expected to defer $5 million to $10 million of revenue into future years, impacting short-term revenue recognition.
• Adjusted gross margins are under pressure due to the transition and costs associated with new product lines like eXpedite, which is still operating at subscale manufacturing costs.
• The reliance on one-time revenue recognition from legacy contracts may not be sustainable in the long term, as indicated by the expected decline in IP license revenue.

5. Notable Q&A Insights

• Over 50% of bookings in Q3 came from existing customers, indicating strong customer retention and expansion.
• The company is optimistic about the new strategic partnership with Plexus, which is expected to enhance manufacturing efficiency and reduce costs.
• The eXpedite product has shown promising attachment rates with Express sales, particularly in the education sector.
• The management emphasized that the transition to direct fulfillment has simplified the purchasing process for channel partners, enhancing their buying experience.

Overall, Evolv Technology reported strong growth in Q3 2025, with strategic shifts aimed at enhancing recurring revenue and operational efficiency. However, the transition period presents challenges in revenue recognition and margin pressures that the company is actively managing.